Accepted Manuscript Cyclic Tetrapeptide HDAC Inhibitors as potential therapeutics for Spinal Mus- cular Atrophy: Screening with iPSC-derived Neuronal Cells Jiun-I Lai, Luke J. Leman, Sherman Ku, Chris J. Vickers, Christian A. Olsen, Ana Montero, M. Reza Ghadiri, Joel M. Gottesfeld PII: S0960-894X(17)30629-7 DOI: http://dx.doi.org/10.1016/j.bmcl.2017.06.027 Reference: BMCL 25061 To appear in: Bioorganic & Medicinal Chemistry Letters Received Date: 29 March 2017 Revised Date: 7 June 2017 Accepted Date: 8 June 2017 Please cite this article as: Lai, J-I., Leman, L.J., Ku, S., Vickers, C.J., Olsen, C.A., Montero, A., Ghadiri, M.R., Gottesfeld, J.M., Cyclic Tetrapeptide HDAC Inhibitors as potential therapeutics for Spinal Muscular Atrophy: Screening with iPSC-derived Neuronal Cells, Bioorganic & Medicinal Chemistry Letters (2017), doi: http:// dx.doi.org/10.1016/j.bmcl.2017.06.027 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.